Monogram Technologies Past Earnings Performance
Past criteria checks 0/6
Monogram Technologies's earnings have been declining at an average annual rate of -26.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 22.2% per year.
Key information
-26.6%
Earnings growth rate
-7.2%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 22.2% |
| Return on equity | -166.1% |
| Net Margin | -3,203.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Monogram Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -12 | 5 | 11 |
| 31 Mar 24 | 0 | -13 | 6 | 11 |
| 31 Dec 23 | 0 | -14 | 7 | 11 |
| 30 Sep 23 | 0 | -13 | 7 | 9 |
| 30 Jun 23 | 0 | -16 | 7 | 8 |
| 31 Mar 23 | 0 | -13 | 4 | 6 |
| 31 Dec 22 | 0 | -14 | 5 | 5 |
| 30 Sep 22 | 0 | -14 | 5 | 5 |
| 30 Jun 22 | 0 | -13 | 6 | 5 |
| 31 Mar 22 | 0 | -14 | 7 | 5 |
| 31 Dec 21 | 1 | -12 | 5 | 5 |
| 30 Sep 21 | 1 | -10 | 4 | 5 |
| 30 Jun 21 | 1 | -9 | 3 | 4 |
| 31 Mar 21 | 0 | -9 | 3 | 4 |
| 31 Dec 20 | 0 | -9 | 2 | 5 |
| 30 Sep 20 | 0 | -8 | 2 | 4 |
| 30 Jun 20 | 0 | -6 | 3 | 3 |
| 31 Mar 20 | 0 | -4 | 2 | 2 |
| 31 Dec 19 | 0 | -2 | 1 | 0 |
| 30 Sep 19 | 0 | -1 | 1 | 0 |
| 30 Jun 19 | 0 | -1 | 1 | 0 |
| 31 Mar 19 | 0 | -1 | 1 | 0 |
| 31 Dec 18 | 0 | -1 | 1 | 0 |
Quality Earnings: J7J is currently unprofitable.
Growing Profit Margin: J7J is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: J7J is unprofitable, and losses have increased over the past 5 years at a rate of 26.6% per year.
Accelerating Growth: Unable to compare J7J's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: J7J is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: J7J has a negative Return on Equity (-166.07%), as it is currently unprofitable.